| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/13/2009 | US7476535 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
| 01/13/2009 | US7476526 Protein for use in generating resistance to bactericides in cells |
| 01/13/2009 | US7476518 Nucleic acids encoding fluorescent proteins and methods of using the same |
| 01/13/2009 | US7476516 Methods for producing biological substances in pigment-deficient mutants of Bacillus cells |
| 01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
| 01/13/2009 | US7476508 bringing a test substance into contact with a screening tool, wherein said screening tool exhibits calcium ion-permeable ion channel activity upon activation with the pregnenolone sulfate |
| 01/13/2009 | US7476391 Attenuated pasteurella for use as tool in developing bactericidal agents; immunotherapy |
| 01/13/2009 | US7476390 Polypeptides and polynucleotides useful in methods of inducing immune response against flaviviruses, including dengue viruses |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | US7476388 Gastrin, and a second dose of an epithelial growth factor; in vivo islet cell regeneration, preexisting diabetes, islet neogenesis |
| 01/13/2009 | US7476387 Chimeric empty viral-like particles derived from the infectious bursal disease virus (IBDV), process for their production and applications |
| 01/13/2009 | US7476386 Mixed lipopeptide micelles for inducing an immune response |
| 01/13/2009 | US7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
| 01/13/2009 | US7476384 Death domain containing receptor 4 antibody and methods |
| 01/13/2009 | US7476381 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury |
| 01/13/2009 | CA2615372A1 Influenza virus-like particles (vlps) comprising hemagglutinin |
| 01/13/2009 | CA2408972C Genes encoding plant transcription factors |
| 01/13/2009 | CA2374729C Novel organic anion transport proteins |
| 01/13/2009 | CA2233932C Vaccines against infections caused by yf virus; yf infectious cdna, method for producing a recombinant yf virus from the yf infectious cdna and plasmids to assemble the yf infectious cdna |
| 01/13/2009 | CA2105534C Tnf ligands |
| 01/08/2009 | WO2009006638A2 Peptides facilitating retrograde transport and their uses |
| 01/08/2009 | WO2009006620A1 Oligosialic acid derivatives, methods of manufacture, and immunological uses |
| 01/08/2009 | WO2009006323A2 Methods and marker combinations for screening for predisposition to lung cancer |
| 01/08/2009 | WO2009006301A2 Protein stabilization |
| 01/08/2009 | WO2009006281A1 Plasmid-encoded neurotoxin genes in clostridium botulinum serotype a subtypes |
| 01/08/2009 | WO2009006112A1 Mdl-1 uses |
| 01/08/2009 | WO2009005917A2 Methods of treating measles infectious disease in mammals |
| 01/08/2009 | WO2009005877A2 Alpha-i antitrypsin having no significant serine protease inhibitor activity |
| 01/08/2009 | WO2009005870A2 Products for prophylaxis and/or treatment of viral diseases and method of making and using same |
| 01/08/2009 | WO2009005040A1 Pseudomonas aeruginosa outer membrane protein pa4710 |
| 01/08/2009 | WO2009004315A1 Isolated peptides and uses thereof |
| 01/08/2009 | WO2009004310A1 Modified globin proteins with attenuated electron transport pathway |
| 01/08/2009 | WO2009004309A1 Modified globin proteins with altered electron transport pathway |
| 01/08/2009 | WO2009004094A2 Compounds and methods for the treatment of renal disease |
| 01/08/2009 | WO2009004058A2 Novel prolactin compounds |
| 01/08/2009 | WO2009004057A2 Mutated dimeric prolactin receptor ligands |
| 01/08/2009 | WO2009004054A2 A cxc chemokine receptor 4 (cxcr4) antagonistic polypeptide |
| 01/08/2009 | WO2009003977A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/08/2009 | WO2009003732A2 Peptides with high affinity for the prolactin receptor |
| 01/08/2009 | WO2009003666A1 Process for the production of pramlintide |
| 01/08/2009 | WO2009003497A1 Diagnostic composition and method for the detection of a trichinella infection |
| 01/08/2009 | WO2009003493A2 Mhc multimers, methods for their generation, labeling and use |
| 01/08/2009 | WO2009003492A1 Mhc multimers, methods for their generation, labeling and use |
| 01/08/2009 | WO2009003491A1 Phage resistance |
| 01/08/2009 | WO2009003412A1 Bacillus thuringiensis stain, cry8g genes, proteins, which are all highly toxic to order coleoptera insect pests, and uses thereof |
| 01/08/2009 | WO2009003291A1 Therapeutics and diagnostics for group a streptococci |
| 01/08/2009 | WO2009003274A1 Susceptibility gene for inflammatory bowel disease |
| 01/08/2009 | WO2008144700A3 Simian t-cell lymphotropic virus type 3 west african subtype d |
| 01/08/2009 | WO2008143709A3 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 01/08/2009 | WO2008142693A3 Regulation of myelination by nectin-like (necl) molecules |
| 01/08/2009 | WO2008140582A3 Production of anti-microbial peptides |
| 01/08/2009 | WO2008138649A3 Signaling peptides |
| 01/08/2009 | WO2008138619A3 New ttv sequences for diagnosis, prevention and treatment of childhood leukaemia |
| 01/08/2009 | WO2008121437A9 Trophinin-binding peptides and uses thereof |
| 01/08/2009 | WO2008119567A3 Cross-species-specific cd3-epsilon binding domain |
| 01/08/2009 | WO2008119566A3 Cross-species-specific bispecific binders |
| 01/08/2009 | WO2008119565A3 Cross-species-specific binding domain |
| 01/08/2009 | WO2008109433A4 Anti-angiogenic peptides |
| 01/08/2009 | WO2008095995A3 Peptidic and non peptidic ligands for immunodetection of the receptor for urotensin ii |
| 01/08/2009 | WO2008067591A8 Protein particles |
| 01/08/2009 | WO2008061156A3 Generation of plants with altered protein, fiber, or oil content |
| 01/08/2009 | WO2008052043A3 Opioid receptor agonist fusion proteins |
| 01/08/2009 | WO2008049113A3 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 01/08/2009 | WO2008028098A3 A novel o-methyltransferase gene from sorghum cloning, expression, transformation and characterization |
| 01/08/2009 | WO2008011379A4 Oxidized apoa1 determination by mass spectrometry |
| 01/08/2009 | WO2006109312A3 Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease |
| 01/08/2009 | US20090013437 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM Zea mays AND ITS USE THEREOF |
| 01/08/2009 | US20090013433 Compositions, cells, and plants that include BKI1, a negative regulator of BRI1-mediated BR signaling |
| 01/08/2009 | US20090013424 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides |
| 01/08/2009 | US20090013423 Methods and compositions for expression of transgenes in plants |
| 01/08/2009 | US20090013421 Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/08/2009 | US20090013417 Transgenic Animals for Assessing Drug Metabolism and Toxicity in Man |
| 01/08/2009 | US20090012280 Oligonucleotide compound and method for treating nidovirus infections |
| 01/08/2009 | US20090012273 Method of Regenerating Elastic Fiber with the Use of Dance or Factor Enhancing the Expression Thereof |
| 01/08/2009 | US20090012270 Ox2 receptor homologs |
| 01/08/2009 | US20090012266 Anti-TNFalpha Antibodies and Methods of Use |
| 01/08/2009 | US20090012265 Purification of polymers carrying a lipophilic group |
| 01/08/2009 | US20090012262 Forisomes, Method for Their Isolation, and Their Use as a Molecular Working Machine |
| 01/08/2009 | US20090012032 novel human genes RNF43 whose expression is markedly elevated in colorectal cancers; genes and polypeptides encoded by the genes can be used in the diagnosis of a cell proliferative disease, and as target molecules for developing drugs against the disease |
| 01/08/2009 | US20090012029 Cyst Nematode Resistant Transgenic Plants |
| 01/08/2009 | US20090012004 HLA binding peptides and their uses |
| 01/08/2009 | US20090012003 Polypeptides homologous to vegf and bmp1 |
| 01/08/2009 | US20090012000 Anti-Viral Peptide and Use Thereof |
| 01/08/2009 | US20090011999 Orally active androctonus amoreuxi pesticidal biopeptides |
| 01/08/2009 | US20090011998 Calcium-influx inhibitory factor and method of isolation thereof |
| 01/08/2009 | US20090011997 Bifunctional hormone and uses thereof |
| 01/08/2009 | US20090011995 Production of a soluble native form of recombinant protein by the signal sequence and secretional enhancer |
| 01/08/2009 | US20090011992 Human Coagulation Factor VII Polypeptides |
| 01/08/2009 | US20090011989 Treating or preventing myocardial contractile dysfunction that occurs after a myocardial infarction or other structural heart disease (e.g., end-stage valve disease) by by administering CaMK11 inhibitor, a peptide having a specific sequence of amino acids; dilated cardiomyopathy; transgenic animals |
| 01/08/2009 | US20090011988 Method for treating cartilage disorders |
| 01/08/2009 | US20090011986 Thiosuccinic Acid Derivatives and the Use Thereof |
| 01/08/2009 | US20090011983 186 Human Secreted Proteins |
| 01/08/2009 | US20090011981 Novel Inhibitors of Angiogenesis |
| 01/08/2009 | US20090011974 Scavenger Receptor B1 (Cla-1) Targeting for the Treatment of Infection, Sepsis and Inflammation |
| 01/08/2009 | US20090011958 Process for immobilizing orientation-controlled protein and process for arraying and immobilizing protein using the same |
| 01/08/2009 | US20090011950 Method for detecting oral squamous-cell carcinoma and method for suppressing the same |
| 01/08/2009 | US20090011520 Stable D-dimer liquid preparation |
| 01/08/2009 | US20090011509 Integrase fusion proteins and their use with integrating gene therapy |
| 01/08/2009 | US20090011501 Novel death domain proteins |
| 01/08/2009 | US20090011500 G+c rich binding protein |